Metraipolis › archive › dc_8a505cb35287
Prognostic significance of PET/CT for CAR T cell therapy in relapsed/refractory multiple myeloma — Europe PMC PMID:40519771
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40519771
- DOI
- 10.1002/hem3.70159
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T06:45:41.836Z
- SHA-256 of the archived text
aacfeb85e3a4bed35415b9498f3e8d517eebb5ffa088659df0502a64575fb05c- Stable URL of this page
https://metraipolis.com/documento/dc_8a505cb35287
How to cite
Prognostic significance of PET/CT for CAR T cell therapy in relapsed/refractory multiple myeloma — Europe PMC PMID:40519771 — Europe PMC (en), https://europepmc.org/article/MED/40519771 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8a505cb35287 (Metraipolis archive dc_8a505cb35287, sha256 aacfeb85e3a4bed35415b9498f3e8d517eebb5ffa088659df0502a64575fb05c)
BibTeX
@misc{dc8a505cb35287,
title = {Prognostic significance of PET/CT for CAR T cell therapy in relapsed/refractory multiple myeloma — Europe PMC PMID:40519771},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40519771},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8a505cb35287; sha256 aacfeb85e3a4bed35415b9498f3e8d517eebb5ffa088659df0502a64575fb05c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40519771. Agents can read the archived copy with the MCP tool read_document.